Log In

Status Information

Status
TRIAL

Term Description

This term is intended to collate similar measurements for the LOINC SNOMED CT Collaboration in an ontological view. Additionally, it can be used to communicate a laboratory order, either alone or in combination with specimen or other information in the order. It may NOT be used to report back the measured patient value. https://lo.inc/ce2mb6

Part Descriptions

LP447904-6   {Measurement}
{Measurement} is a Property grouper part used to collate terms with comparable measurement-related properties. It encompasses the following LOINC Properties: ACnc, AFr, ARat, CAct, CCnc, CCnt, CRat, CSub, EntLen, LaCnc, LnCnc, Mass, MCnc, MCnt, MRat, MRto, MSCnc, MSRat, Naric, NCnc, NFr, Prctl, PrThr, Ratio, SatFr, SCnc, SCnt, SRat, SRto, Sub, ThreshNum, Titr, and TmMCn. Source: Regenstrief LOINC

LP64671-8   Natalizumab
Natalizumab is a humanized monoclonal antibody against the cellular adhesion molecule α4-integrin. Natalizumab is used in the treatment of multiple sclerosis and Crohn's disease. The drug is believed to work by reducing the ability of inflammatory immune cells to attach to and pass through the cell layers lining the intestines and blood-brain barrier. Natalizumab has proven effective in treating the symptoms of both diseases, preventing relapse, vision loss, cognitive decline and significantly improving quality of life in people with multiple sclerosis, as well as increasing rates of remission and preventing relapse in Crohn's disease. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Wikipedia

LP64672-6   Natalizumab Ab
Drug therapy for MS - loses effectiveness when patients develop antibodies to the drug. Detecting the antibodies early allows healthcare providers the opportunity to prescribe alternative therapy and avoid the cost associated with failed therapy. Source: Regenstrief Institute

LOINC Names Get Info

Fully-Specified Name
Natalizumab Ab:{Measurement}:-:Ser:-:
Long Common Name
Natalizumab Ab [Measurement] in Serum
Short Name
Natalizumab Ab Msmt Ser
Display Name
Natalizumab Ab (S) [Measurement]
Consumer Name Alpha Get Info
Natalizumab antibody, Blood

Part Model Get Info

  • Component
    Natalizumab Ab
    LP64672-6
    • Analyte
      Natalizumab Ab
      LP64672-6
      • Component Numerator
        Natalizumab Ab
        LP64672-6
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    {Measurement}
    LP447904-6
  • Time
    -
    LP70420-2
  • System
    Ser
    LP7567-3
    • System Core
      Ser
      LP7567-3
    • Super System
      NULL
       
  • Scale
    -
    LP7747-1
  • Method
    NULL
     

Basic Attributes

Class
LABORDERS.ONTOLOGY
Type
Laboratory
First Released
Version 2.81
Last Updated
Version 2.81 (ADD)
Order vs. Observation
Order

Language Variants Get Info

TagLanguageTranslation
es-ESSpanish (Spain)Natilizumab Anticuerpos:Medición:-:Suero:-:
fr-FRFrench (France)Natalizumab Ac:{Mesure}:-:Sérum:-:
it-ITItalian (Italy)Natalizumab Ab:{Misurazione}:-:Siero:-:
Synonyms: anticorpo Codici richieste di laboratorio LABORDERS.ONTOLOGY Misurazione Siero
pl-PLPolish (Poland)Natalizumab Ab:{Oznaczenie}:-:surowica:-:
Synonyms: Natalizumab
zh-CNChinese (China)那他珠单抗 抗体:{检测}:-:血清:-:
Synonyms: {测量};{测定};{检测结果};{测量结果};{测定结果} Ab;自身抗体 Natalizumab Ab Natalizumab 抗体 Natalizumab;Natalizumab 单抗;Tysabri;那他株单抗;那他珠单克隆抗体 多重;多重型;多重标尺类型;多重精度类型 实验室检验项目医嘱类;检验项目医嘱;检验项目申请;化验项目申请 检验申请.本体;实验室检验医嘱.本体 那他珠单抗 Ab

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=108996-0